Form 4: Director Jeff Epstein Acquires AvePoint Shares

AvePoint, Inc. director Jeff Epstein acquired 16,493 shares of common stock via restricted stock unit grant.

Summary

• Director Jeff Epstein received a grant of 16,493 restricted stock units (RSUs) on June 1, 2026.
• Each RSU represents a contingent right to receive one share of AvePoint common stock.
• The transaction was valued at $11.52 per share.
• Following this transaction, the director's total beneficial ownership stands at 1,184,128 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine disclosure of director equity compensation that does not signal a change in company strategy or financial health.

Positives

• Director alignment with shareholder interests through equity-based compensation.
• The grant indicates continued commitment from a board member.

Negatives

• None identified; this is a standard equity compensation disclosure.

Risks

• Vesting is contingent upon the director's continued service with the issuer through the vesting date.

Future Outlook

The RSUs are scheduled to vest in full on June 1, 2027, subject to the director's continued service.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practices designed to align board incentives with long-term shareholder value in the software and SaaS sector.

Comparison to Industry Standards

• The use of 2021 Equity Incentive Plans is consistent with standard practices for publicly traded technology companies.
• Director compensation structures involving RSU grants are common among mid-cap software firms.

Stakeholder Impact

• Increased alignment between board members and shareholders.

Next Steps

• Vesting of the 16,493 RSUs on June 1, 2027.

Key Dates

Keywords

AvePoint, AVPT, Insider Trading, Form 4, Equity Compensation, Director Ownership